PharmaShots | Incisive News in 3 Shots

Subscribe Now

Differentiated Thyroid Cancer

$Ipsen’s Cabometyx Receives EC’s Approval as a 2L treatment for Radioactive Iodine-Refractory Differentiated Thyroid Cancer$

Ipsen’s Cabometyx Receives EC’s Approval as a 2L treatment for Radioactive Iodine-Refractory Differentiated Thyroid Cancer

May 3, 2022

$Ipsen’s Cabometyx Receives CHMP's Recommendation for Approval in the EU to Treat Radioactive Iodine-Refractory Differentiated Thyroid Cancer$

Ipsen’s Cabometyx Receives CHMP's Recommendation for Approval in the EU to Treat Radioactive Iodine-Refractory Differentiated Thyr...

March 28, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us